Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of 480 Biomedical Sinus Drug Depot (LYR-210) in Chronic Sinusitis
NCT02967731Phase 1Completed
- Sponsor
- Lyra Therapeutics, Inc.
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of mometasone in chronic rhinosinusitis (CRS), sponsored by Lyra Therapeutics, Inc. Primary endpoint: Product related serious adverse events. Started Jun 2017; status: completed.
02
Drugs
mometasone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02967731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967731.